Remarkable technical advances have permitted analytical measurement of
thyrotropin (TSH) and estimates of free thyroxine (ET(4)) with precis
ion, accuracy, and favorable economics. Combined with an increased app
reciation of the key insights into the pituitary-thyroid relation, pre
analytical considerations infrequently introduce confounding variables
. In reviewing thyroid data, preanalytical considerations include phys
iological and specimen-based issues. Central to the improvement in thy
roid assessment is the recognition that physiological individuals main
tain their FT4 within narrow limits. When this deviates, there is a lo
garithmic response of the TSH concentration to the arithmetic shift in
FT4. In effect, the TSH deviation magnifies the subtle shift in FT4.
Artifact and other nonthyroid-related preanalytical considerations are
infrequently the cause of nonconcordance when discrepancy occurs betw
een the reported values for FT4 and TSH. When abnormalities of TSH and
FT4 are encountered, the probability strongly favors a disease state
rather than a preanalytical variable. Infrequent but real extrathyroid
al pathophysiological states are increasingly recognized as a result o
f the reliable assessment of the pituitary-thyroid relation.